FEDRATINIB for Myeloproliferative neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 146 adverse event reports in the FDA FAERS database where FEDRATINIB was used for Myeloproliferative neoplasm.
Most Reported Side Effects for FEDRATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 143 | 10.2% | 13 | 28 |
| Death | 138 | 9.8% | 138 | 3 |
| Nausea | 114 | 8.1% | 0 | 13 |
| Fatigue | 105 | 7.5% | 0 | 10 |
| Vomiting | 74 | 5.3% | 10 | 20 |
| Constipation | 59 | 4.2% | 9 | 18 |
| Platelet count decreased | 48 | 3.4% | 0 | 10 |
| Asthenia | 47 | 3.4% | 2 | 14 |
| Haemoglobin decreased | 46 | 3.3% | 1 | 12 |
| Full blood count decreased | 45 | 3.2% | 0 | 14 |
| Drug ineffective | 42 | 3.0% | 0 | 1 |
| Anaemia | 41 | 2.9% | 1 | 11 |
| Off label use | 40 | 2.9% | 7 | 6 |
| Dizziness | 37 | 2.6% | 0 | 8 |
| Illness | 34 | 2.4% | 1 | 6 |
Other Indications for FEDRATINIB
Myelofibrosis (682)
Product used for unknown indication (307)
Primary myelofibrosis (77)
Polycythaemia vera (69)
Off label use (56)
Essential thrombocythaemia (28)
Myelodysplastic syndrome (27)
Splenomegaly (11)
Hairy cell leukaemia (9)
Thrombocytosis (8)
Other Drugs Used for Myeloproliferative neoplasm
RUXOLITINIB (2,982)
PACRITINIB (365)
LENALIDOMIDE (163)
HYDROXYUREA (162)
AZACITIDINE (99)
VENETOCLAX (94)
PEGINTERFERON ALFA-2A (75)
IMATINIB (71)
THALIDOMIDE (56)
ROPEGINTERFERON ALFA-2B-NJFT (54)